POSSIBLE RATIONAL FOR PROCAINE (GEROVITAL H-3) THERAPY IN GERIATRICS - INHIBITION OF MONOAMINE-OXIDASE

被引：26

作者：

MACFARLANE, MD ^{[1
]}

机构：

[1] UNIV SO CALIF, SCH PHARM, LOS ANGELES, CA 90007 USA

来源：

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 1973年 / 21卷 / 09期

关键词：

D O I：

10.1111/j.1532-5415.1973.tb01701.x

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：414 / 418

页数：5

共 31 条

[1] THE EFFECTS OF A EUROPEAN PROCAINE PREPARATION IN AN AGED POPULATION .1. PSYCHOLOGICAL EFFECTS [J].

ABRAMS, A ;

TOBIN, SS ;

GORDON, P ;

PECHTEL, C ;

HILKEVITCH, A .

JOURNALS OF GERONTOLOGY, 1965, 20 (02) :139-143

[2]

Aslan A., 1956, THERAPIEWOCHE, V7, P14

[3]

ASLAN A, 1962, MEDICAL CLINICAL ASP

[4]

BATSON HD, 1963, INTO STATISTICS MEDI

[5] RELATIONSHIP OF MONOAMINE METABOLITES IN HUMAN CEREBROSPINAL FLUID TO AGE [J].

BOWERS, MB ;

GERBODE, FA .

NATURE, 1968, 219 (5160) :1256-&

[6]

BUCCI L, 1960, J NEUROPSYCHIATRY, V1, P276

[7]

CRANE GE, 1970, PRINCIPLES PSYCHOPHA

[8] PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORS [J].

EVERETT, GM ;

WIEGAND, RG ;

RINALDI, FU .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1963, 107 (03) :1068-&

[9]

FRIEDMAN OL, 1964, EXCERPTA MED, V7, P159

[10]

FULLER RW, 1972, ADV BIOCHEMICAL PHAR, V5

← 1 2 3 4 →